MX2023004594A - Un metodo de almacenamiento de celulas endoteliales de la cornea humanas y/o celulas precursoras endoteliales de la cornea humanas. - Google Patents
Un metodo de almacenamiento de celulas endoteliales de la cornea humanas y/o celulas precursoras endoteliales de la cornea humanas.Info
- Publication number
- MX2023004594A MX2023004594A MX2023004594A MX2023004594A MX2023004594A MX 2023004594 A MX2023004594 A MX 2023004594A MX 2023004594 A MX2023004594 A MX 2023004594A MX 2023004594 A MX2023004594 A MX 2023004594A MX 2023004594 A MX2023004594 A MX 2023004594A
- Authority
- MX
- Mexico
- Prior art keywords
- cells
- corneal endothelial
- human corneal
- time
- sup
- Prior art date
Links
- 210000000399 corneal endothelial cell Anatomy 0.000 title abstract 6
- 230000003511 endothelial effect Effects 0.000 title abstract 6
- 210000000130 stem cell Anatomy 0.000 title abstract 6
- 238000004321 preservation Methods 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 210000004027 cell Anatomy 0.000 abstract 7
- 102100032912 CD44 antigen Human genes 0.000 abstract 2
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 abstract 2
- 239000001963 growth medium Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000004660 morphological change Effects 0.000 abstract 1
- 239000011435 rock Substances 0.000 abstract 1
- 230000004083 survival effect Effects 0.000 abstract 1
- 230000009466 transformation Effects 0.000 abstract 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0278—Physical preservation processes
- A01N1/0284—Temperature processes, i.e. using a designated change in temperature over time
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/04—Preserving or maintaining viable microorganisms
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
- A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/72—Transferases (EC 2.)
- C12N2501/727—Kinases (EC 2.7.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/54—Collagen; Gelatin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Developmental Biology & Embryology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Ophthalmology & Optometry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Physiology (AREA)
- Biophysics (AREA)
- Reproductive Health (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gynecology & Obstetrics (AREA)
- Hematology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Materials For Medical Uses (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
Abstract
Las células endoteliales de la córnea humana y/o las células precursoras endoteliales de la córnea humana se conservan con una alta tasa de supervivencia de estas células manteniéndose, y se suprime la tasa de aparición de células contaminadas en el cultivo posterior a la conservación. Un método de almacenamiento de células endoteliales de la córnea humana y/o células precursoras endoteliales de la córnea humana se caracteriza porque las células endoteliales de la córnea humana y/o las células precursoras endoteliales de la córnea humana que han sido cultivadas utilizando un medio de cultivo que contiene un inhibidor de ROCK, y en el que el contenido de factor de crecimiento epidérmico (EGF) es menor que una concentración que causará una transformación se recolectan en un tiempo en que se cumple cualquiera de o una pluralidad de las condiciones (a) ~ (d) que se indican a continuación, y se colocan en un estado de suspensión y luego de conservado. (a) Durante un período inmediatamente después de que una morfología de las células endoteliales de la córnea humana y/o de las células precursoras endoteliales de la córnea humana haya cambiado de una forma fusiforme a una forma poligonal o una forma elíptica cuya proporción eje mayor-eje menor es cercana a 1, hasta inmediatamente antes de que los límites entre las células se vuelvan indistintos. (b) Durante un período desde que un nivel de expresión de CD44 se vuelve igual o inferior a la mitad del valor máximo observado después del subcultivo más reciente hasta que este nivel de expresión alcanza una meseta. (c) Cuando la densidad celular de las células endoteliales de la córnea humana y/o de las células precursoras endoteliales de la córnea humana no sea inferior a 900 células/mm2 ni superior a 2500 células/mm2. (d) Cuando el número de días de cultivo desde el subcultivo más reciente no sea inferior a 4 días ni superior a 14 días.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020177634 | 2020-10-22 | ||
PCT/JP2021/038609 WO2022085680A1 (ja) | 2020-10-22 | 2021-10-19 | ヒト角膜内皮細胞及び/又はヒト角膜内皮前駆細胞の保存方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2023004594A true MX2023004594A (es) | 2023-05-08 |
Family
ID=81290627
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2023004594A MX2023004594A (es) | 2020-10-22 | 2021-10-19 | Un metodo de almacenamiento de celulas endoteliales de la cornea humanas y/o celulas precursoras endoteliales de la cornea humanas. |
Country Status (10)
Country | Link |
---|---|
US (1) | US20230380417A1 (es) |
EP (1) | EP4234682A1 (es) |
JP (2) | JP7361431B2 (es) |
KR (1) | KR20230091107A (es) |
CN (1) | CN116583593A (es) |
AU (1) | AU2021366805A1 (es) |
CA (1) | CA3196110A1 (es) |
IL (1) | IL302168A (es) |
MX (1) | MX2023004594A (es) |
WO (1) | WO2022085680A1 (es) |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4678783B1 (en) | 1983-11-04 | 1995-04-04 | Asahi Chemical Ind | Substituted isoquinolinesulfonyl compounds |
JPH0276977A (ja) | 1988-09-12 | 1990-03-16 | Matsushita Electric Ind Co Ltd | 湯水混合装置 |
JPH0276976A (ja) | 1988-09-12 | 1990-03-16 | Matsushita Electric Ind Co Ltd | 制御弁 |
JPH02100833A (ja) | 1988-10-07 | 1990-04-12 | Tokai T R W Kk | 転造ダイスの加工方法 |
JPH0359913A (ja) | 1989-07-28 | 1991-03-14 | Yazaki Corp | 金属溶射による回路体の製造方法 |
JPH0362227A (ja) | 1989-07-31 | 1991-03-18 | Nec Corp | 高速再翻訳処理方式 |
JPH04620A (ja) | 1990-04-18 | 1992-01-06 | Nec Off Syst Ltd | キーボード |
JPH081403A (ja) | 1994-06-22 | 1996-01-09 | Fukui Seisakusho:Kk | Nc装置付き工作機械によるネジ端部バリ取り方法 |
JP3906284B2 (ja) | 1995-04-14 | 2007-04-18 | 株式会社東芝 | 光ディスクからビデオ及びオーディオを再生する再生システム、その再生方法及び光ディスクの記録方法 |
JP3421217B2 (ja) | 1995-11-20 | 2003-06-30 | 麒麟麦酒株式会社 | Rho標的タンパク質Rhoキナーゼ |
JP4315407B2 (ja) | 2000-09-07 | 2009-08-19 | コスモ石油株式会社 | 競合見積管理システムおよび方法、並びに購買ウエブサーバ |
JP2004009555A (ja) | 2002-06-07 | 2004-01-15 | Futec Inc | 印刷欠点の検出装置および検出方法 |
US6911772B2 (en) | 2002-06-12 | 2005-06-28 | Eastman Kodak Company | Oled display having color filters for improving contrast |
JP4023271B2 (ja) | 2002-09-20 | 2007-12-19 | 株式会社トヨトミ | 窓用空気調和機の構造 |
JP2005003101A (ja) | 2003-06-12 | 2005-01-06 | Toyota Motor Corp | 無段変速機の制御装置 |
JP2005035501A (ja) | 2003-07-14 | 2005-02-10 | Takahisa Tsutsui | 油タンカー船の積付け計算をボタン操作によって調整かつ、連動して海面を表示するプログラム |
JP2005035503A (ja) | 2003-07-15 | 2005-02-10 | Okubo Tomio | 自転車等の防寒用ハンドルカバー |
JP2005039564A (ja) | 2003-07-16 | 2005-02-10 | Nec Saitama Ltd | 画像配信システム、サーバ装置、携帯端末装置及びそれに用いる画像配信方法 |
JP2005035506A (ja) | 2003-07-17 | 2005-02-10 | Masuo Kato | パイプを使用した水上、水中液体貯蔵装置及び水上輸送方法 |
JP4160460B2 (ja) | 2003-07-18 | 2008-10-01 | ヤマザキマザック株式会社 | レーザ加工機 |
JP2005037198A (ja) | 2003-07-18 | 2005-02-10 | Kawasaki Heavy Ind Ltd | 内側炉心槽の挿入・引き抜き方法及びその装置と内側炉心槽引き抜き時の燃料集合体の拘束支持方法及びその装置 |
JP2005037197A (ja) | 2003-07-18 | 2005-02-10 | Ricoh Co Ltd | 接触式表面形状測定装置及び測定方法 |
JP3759133B2 (ja) | 2003-08-29 | 2006-03-22 | ローム株式会社 | 電源装置 |
JP4315279B2 (ja) | 2003-09-30 | 2009-08-19 | 能美防災株式会社 | 消防用設備の開閉弁装置及びその制御弁 |
JP2006057270A (ja) | 2004-08-18 | 2006-03-02 | Akimori Taniguchi | 巨大水母類の漂着による、取水口スクリ−ン吸着閉塞防止システム。 |
US20060101035A1 (en) | 2004-11-11 | 2006-05-11 | Mustakallio Minna M | System and method for blog functionality |
US9248125B2 (en) * | 2007-08-29 | 2016-02-02 | Senju Pharmaceutical Co., Ltd. | Agent for promoting corneal endothelial cell adhesion |
WO2014038639A1 (ja) * | 2012-09-07 | 2014-03-13 | 日本ケミカルリサーチ株式会社 | 間葉系幹細胞の馴化培地を含有する角膜内皮細胞培養用培地 |
JP6637656B2 (ja) * | 2014-01-16 | 2020-01-29 | 千寿製薬株式会社 | 角膜内皮細胞を含有する移植用組成物 |
CN107206563A (zh) | 2015-02-13 | 2017-09-26 | P和L合资有限公司 | 用于确定工件在机床中的位置的方法 |
EP3395364B1 (en) | 2015-12-24 | 2021-10-20 | The Doshisha | Caspase inhibitor-containing drug for treating or preventing disorders caused by tgf-beta , and applications thereof |
ES2947826T3 (es) * | 2016-02-15 | 2023-08-21 | Kyoto Prefectural Public Univ Corp | Célula endotelial corneal funcional humana y aplicación de la misma |
CN112514488A (zh) | 2018-08-09 | 2021-03-16 | 夏普株式会社 | 集成接入和回程网络中的集成接入和回程节点识别 |
JP2020032139A (ja) | 2018-08-31 | 2020-03-05 | 株式会社三洋物産 | 遊技機 |
-
2021
- 2021-10-19 WO PCT/JP2021/038609 patent/WO2022085680A1/ja active Application Filing
- 2021-10-19 IL IL302168A patent/IL302168A/en unknown
- 2021-10-19 MX MX2023004594A patent/MX2023004594A/es unknown
- 2021-10-19 US US18/032,726 patent/US20230380417A1/en active Pending
- 2021-10-19 CN CN202180072227.5A patent/CN116583593A/zh active Pending
- 2021-10-19 KR KR1020237014236A patent/KR20230091107A/ko unknown
- 2021-10-19 EP EP21882821.8A patent/EP4234682A1/en active Pending
- 2021-10-19 AU AU2021366805A patent/AU2021366805A1/en active Pending
- 2021-10-19 JP JP2022557558A patent/JP7361431B2/ja active Active
- 2021-10-19 CA CA3196110A patent/CA3196110A1/en active Pending
-
2023
- 2023-07-21 JP JP2023119210A patent/JP2023139164A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP4234682A1 (en) | 2023-08-30 |
JPWO2022085680A1 (es) | 2022-04-28 |
CA3196110A1 (en) | 2022-04-28 |
WO2022085680A1 (ja) | 2022-04-28 |
IL302168A (en) | 2023-06-01 |
JP7361431B2 (ja) | 2023-10-16 |
CN116583593A (zh) | 2023-08-11 |
AU2021366805A1 (en) | 2023-06-22 |
KR20230091107A (ko) | 2023-06-22 |
US20230380417A1 (en) | 2023-11-30 |
JP2023139164A (ja) | 2023-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108849855B (zh) | 一种脂肪组织离体保存液及其制备方法 | |
CN104560870B (zh) | 一种制备蜕膜间充质干细胞的方法 | |
JP2017148079A5 (es) | ||
JPWO2018143258A1 (ja) | 多分化能性幹細胞増殖促進剤 | |
CN105076114A (zh) | 脐带间充质干细胞无血清保存液及其应用 | |
CN108184818A (zh) | 一种人胎盘间充质干细胞悬液保护剂 | |
CN103380769A (zh) | 用于分离培养干细胞的脂肪组织的长时间保存液 | |
CN105248413A (zh) | 一种cik细胞冻存液 | |
MX2022006591A (es) | Métodos para mejorar el cultivo celular con proteínas específicas de cada especie o específicas de cada género y las aplicaciones de los mismos. | |
CN103704206A (zh) | 胎盘保存液 | |
CN103087982A (zh) | 一种快速分离脂肪间充质干细胞的试剂盒及方法 | |
CN104830758A (zh) | 一种间充质干细胞成骨诱导分化培养基及其制备方法 | |
CN112391340A (zh) | 一种间充质干细胞培养基 | |
MX2023004594A (es) | Un metodo de almacenamiento de celulas endoteliales de la cornea humanas y/o celulas precursoras endoteliales de la cornea humanas. | |
CN104472474A (zh) | 一种人脂肪间充质干细胞冻存液 | |
MX2020005668A (es) | Metodo de cultivo de celulas. | |
Street et al. | Factors Controiling Meristematic Activity in Excised Roots. II. Experiments Involving Repeated Subeulture of the Main Axis Meristem of Roots of Lycopersicum esculentum. Mill. and Lycopersicum PimpinellifoHum, Dunal. | |
CN108719275A (zh) | 一种用于体外保存脂肪颗粒的保存液及其使用方法 | |
JP2018000194A (ja) | 骨格筋初代細胞の培養液 | |
CN115590015A (zh) | 一种脐带间充质干细胞冻存保护剂及冻存方法 | |
CN104818239B (zh) | 一种暗色唇鱼肝脏细胞系的构建方法 | |
Lipetz | The fine structure of plant tumors: I. Comparison of crown gall and hyperplastic cells | |
CN113249313A (zh) | 一种细胞高贴壁能力的干细胞原代培养方法 | |
JPS63216476A (ja) | 無血清凍結保存用培地 | |
JPWO2022085680A5 (es) |